These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4058642)

  • 1. Epidemiologic issues in neurotoxicity research.
    Baker EL
    Neurobehav Toxicol Teratol; 1985; 7(4):293-7. PubMed ID: 4058642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic studies: pitfalls in interpretation.
    Westhoff CL
    Dialogues Contracept; 1995; 4(5):5-6, 8. PubMed ID: 12288680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupational epidemiologic study design and application.
    Blair A; Hayes RB; Stewart PA; Zahm SH
    Occup Med; 1996; 11(3):403-19. PubMed ID: 8887376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of small effect sizes in occupational and environmental neurotoxicology: individual versus population risk.
    Bellinger DC
    Neurotoxicology; 2007 Mar; 28(2):245-51. PubMed ID: 16806481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating epidemiology and toxicology in neurotoxicity risk assessment.
    Boyes WK; Moser VC; Geller AM; Benignus VA; Bushnell PJ; Kamel F
    Hum Exp Toxicol; 2007 Apr; 26(4):283-93. PubMed ID: 17615109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the prevention of environmental neurotoxic illness.
    Landrigan PJ; Graham DG; Thomas RD
    Environ Res; 1993 Apr; 61(1):157-63. PubMed ID: 8472670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation and application of delayed neurotoxicity test data from regulatory and legal viewpoints: panel discussion.
    Rosenstein LS; Maddy KT; Sette WF; Mendoza CE; Beyer SV
    Neurotoxicology; 1983; 4(4):85-97. PubMed ID: 6686874
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies.
    Hudnell HK
    Neurotoxicology; 1999; 20(2-3):379-97. PubMed ID: 10385898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome.
    Horwitz RI; Daniels SR
    J Rheumatol Suppl; 1996 Oct; 46():60-72. PubMed ID: 8895182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interpretation of occupational epidemiologic data in regulation and litigation: studies of auto mechanics and petroleum workers.
    Wong O
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):191-7. PubMed ID: 16464525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methodology of a study on insomnia in the general population].
    Ohayon MM
    Encephale; 2002; 28(3 Pt 1):217-26. PubMed ID: 12091782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introductory remarks to workshop on neurotoxicity testing in human populations. October 14-16, 1983.
    Reiter LW
    Neurobehav Toxicol Teratol; 1985; 7(4):287-8. PubMed ID: 4058640
    [No Abstract]   [Full Text] [Related]  

  • 15. Occupational aluminum exposure: evidence in support of its neurobehavioral impact.
    Meyer-Baron M; Schäper M; Knapp G; van Thriel C
    Neurotoxicology; 2007 Nov; 28(6):1068-78. PubMed ID: 17692380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on incorporating human neurobehavioral end points in risk assessments.
    Bellinger DC
    Risk Anal; 2002 Jun; 22(3):487-98. PubMed ID: 12088228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall design considerations in male and female occupational reproductive studies.
    Sever LE; Hessol NA
    Prog Clin Biol Res; 1984; 160():15-47. PubMed ID: 6332322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on case-control in the framework of research on oral contraceptive side effects].
    Annus J
    Orvoskepzes; 1986 Jul; 61(4):243-59. PubMed ID: 12282268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computer-administered neurobehavioral evaluation system for occupational and environmental epidemiology. Rationale, methodology, and pilot study results.
    Baker EL; Letz R; Fidler A
    J Occup Med; 1985 Mar; 27(3):206-12. PubMed ID: 3981277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative memory disorders: a potential role of environmental toxins.
    Caban-Holt A; Mattingly M; Cooper G; Schmitt FA
    Neurol Clin; 2005 May; 23(2):485-521. PubMed ID: 15757794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.